Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab

计划入组 500 人 · 首次发布于 2017 年 4 月 11 日

Ustekinumab Real World Evidence Study

计划入组 601 人 · 首次发布于 2026 年 8 月 5 日

A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to European Union (EU) Sourced Stelara and United States of America (US) Sourced Stelara in Healthy Subjects

计划入组 201 人 · 首次发布于 2021 年 2 月 26 日

Ustekinumab biosimilar

Ustekinumab(Stelara, Pyzchiva, Uzpruvo, Wezenla, Steqeyma, Otulfi, Fymskina, Eksunbi, Absimky, Imuldosa, Yesintek, Qoyvolma, Usymro, Usrenty, Usgena)

Rx

USTEKINUMAB-AEKN

SELF SPONSORED

United States

Self Storage Group Inc

United States

RESTECH SRL

Italy

FDA Approves Accord BioPharma's IMULDOSA (Ustekinumab-srlf) as Biosimilar

FDA Approves Accord BioPharma's IMULDOSA, a Biosimilar to Stelara, for Inflammatory Conditions

Imuldosa (Ustekinumab-srlf) Receives FDA Approval as Stelara Biosimilar